Dialysis Access Management is the process of screening patients for dialysis access, maintaining its function, and monitoring patient outcomes. It also assists in monitoring therapies that could improve the management of these diseases. The role of medical treatment in managing chronic renal failure has been outstanding in recent years. Each year, progress is made in the development of slow and fast-acting agents that inhibit or block key mediators of tubulointerstitial injury, thus increasing life expectancy.
Today, more than half of all chronic renal failure patients in San Antonio are on dialysis.CKD patients, particularly those on dialysis, can benefit from San Antonio dialysis access management. This multidisciplinary team approach focuses on patients’ vascular access and works to optimize health outcomes. CKD patients experience better life expectancy than ever before because of better rates of prevention and early detection.
Who Needs It?
Any patient with kidney disease needs access management, which can include everyone who has end-stage renal disease (ESRD), AIDS-related kidney disease (also called HIV nephropathy), or Chronic Kidney Disease (CKD) stage 3 or higher.
Benefits of Good Dialysis Access Management
The benefits of good access management are that it will help improve patients’ vascular access function, impacting their life expectancy. Patients can get dialysis more frequently than if they had poor vascular access, leading to better health outcomes. Good access management also helps prevent infection.
Good dialysis access management may help improve patient survival during their dialysis treatment. Patients on dialysis will typically receive more frequent treatments if they have good vascular access instead of poor vascular access. One study found a 31% reduction in mortality for patients with good vascular access compared to those with poor vascular access.
What Techniques Are Used?
The technique used to access the vascular system can be through a fistula, graft, or arteriovenous (AV) fistula.
A fistula is formed by joining an artery and a vein, usually in the upper arm. It allows blood to flow directly from arteries to veins, avoiding the need for blood-thinning medication to get into the bloodstream. To form a fistula, blood vessels are surgically joined under a local anesthetic. The new “fistula” is made up of tissues taken from elsewhere in the body.
A graft is an artificial tube inserted to allow blood to flow between two blood vessels or organs. It’s often used to replace damaged or diseased blood vessels and other tissue and bypass blocked arteries.
An AV fistula allows the patient’s blood to flow directly from an artery into a vein without going through an artificial graft. The patient may have two fistulas in each arm or just one fistula on one side of the body. Each fistula must be used in rotation to prevent damage to the area.
In summary, Dialysis Access Management is the process of screening patients for dialysis access, maintaining its function, and monitoring patient outcomes. You may need it if you have any form of kidney disease. It can help improve vascular access function and your survival during dialysis treatment.
It involves three different techniques: fistula, graft, or an arteriovenous (AV) fistula.
